ATLANTA, GA, USA I December 11, 2024 I Expression Therapeutics, Inc., has presented the results of a Phase 1 clinical trial for its novel lentiviral ...

Enrollment in the Phase 1/2 ASTRA study is set to start in the first half of 2025. The study will observe the safety and ...

Good day, and welcome to the Q4 and FY24 Adobe Earnings Conference Call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Steve Day, SVP, DX, CFO and ...

Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company successfully integrated Recraft AI into ...

The Vericheck ddPCR Empty-Full Capsid Kits comprise a capsid detection assay in FAM and an ITR-2 assay in HEX. The ITR-2 ...

Given the recent impatience (petulence?) seen on Wall Street around AI on what diginomica has dubbed ‘show us the money’ ...

Vector genome maps for plasmids used in the AAV triple plasmid transfection assay ... and content for the areas of cell ...

This study explores speech-based personality prediction using deep learning, analyzing acoustic and linguistic features to ...

What began as a playful TikTok trend ignited a broader conversation about individuality, self-expression, and challenging societal norms. From fashion runways to social media feeds, the word “demure” ...

Operator Good day, and welcome to the Q4 and FY '24 Adobe earnings conference call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Steve Day, SVP, DX; CFO; ...

Mike Durbin on Cetera's M&A plans, why consolidation will barrel forward in the wealth management industry and the advantages ...